Alaa Abd-Elsayed, MD, MPH
Dr. Abd-Elsayed’s research interests involve finding new clinical strategies to reduce chronic pain and for general pain management treatment. By carefully considering the pathology of the pain and treating the whole patient, we have been able to treat many patients with state-of-the-art therapies, including using advanced technology and modalities, that are successful in reducing or blocking pain and dramatically improving their quality of life..
Matthew Banks, PhD
Research in the Banks lab focuses on neural mechanisms of loss and recovery of consciousness under anesthesia, the overlap of these mechanisms with changes in arousal during natural sleep, the link between inflammation and brain function during postoperative delirium, and the mechanisms whereby psychedelics ameliorate psychiatric disorders (depression, substance use disorder).
Kristin Bevil, MD
Dr. Bevil’s lab investigates the incorporation of regional anesthesia techniques in the perioperative treatment of pain to improve patient outcomes as well as further evaluating patients’ understanding of pain and their postsurgical experience.
Guelay Bilen-Rosas, MD
The Bilen-Rosas lab’s mission and passion is to find a solution to prevent catastrophic outcomes by developing a clinically useful respiratory monitoring device.
Molly Groose, MD
The Groose research group focuses on understanding the effects of vitamin C on biochemical and cellular damage in liver transplant recipients to optimize graft outcomes of this scarce resource.
William R. Hartman, MD, PhD
Dr. Hartman’s current research focuses on quick implementation of therapy trial protocols to expeditiously bring novel treatments from the laboratory to the patient. Dr. Hartman concentrates on phase 2 and phase 3 clinical trials. University of Wisconsin-Madison is ideal for these types of trials because of the efficient Office of Clinical Trials staffed with highly skilled and motivated coordinators.
Aaron Hess, MD, PhD
The Hess lab focuses on understanding changes in red cell mass and improving the storage and post-transfusion survival of blood. The Hess lab is investigating a novel technique for red cell mass measurement. Validation of this technique will have major implications for studies of red cell physiology, measurement of blood loss, volume status assessment and progress toward better transfusion therapies.
Kirk Hogan, MD, JD
The Hogan Laboratory focuses on responses to anesthesia and surgery arising from genomic and epigenomic variation.
Jonathan Kay, MD
The Kay lab seeks to validate the immediate action of heparin and thereby the ability to safely go on cardiopulmonary bypass more rapidly than currently practiced even in patients with reduced ejection fraction.
Richard Lennertz, MD, PhD
Seeking novel treatments for chronic pain, the Lennertz research group aims to understand the transition from acute to chronic pain by studying inhibitory neurons in the brain. An additional interest is the analgesic potential of subtype-selective GABA modulators.
K.A. Kelly McQueen, MD, MPH, FASA
Dr. McQueen focuses on studying infrastructure and anesthesia and surgical outcomes in low and middle-income countries. Her 25+ years of research and programing has improved access to surgery and safe anesthesia, patient safety and patient outcomes in Subsaharan Africa and Central America.
Robert A. Pearce, MD, PhD
The Pearce lab seeks to understand how inhibitory circuits in the hippocampus control the formation of memories in health and disease, and how drugs modulate inhibition to suppress memory during anesthesia.
Misha Perouansky, MD
The Perouansky laboratory uses genetic tools available in the fruit fly (Drosophila melanogaster) to identify genetic determinants of anesthetic neurotoxicity.
Benjamin Walker, MD
Dr. Walker’s research is focused on pediatric perioperative pain management strategies. By studying risks and complications in national and international databases, and through direct clinical research, his goal is to advance current anesthesia and prescription practice and improve care for the youngest patients.